Normalization of Hematocrit with Recombinant Human Erythropoietin in Chronic Hemodialysis Patients Does Not Fully Improve Their Exercise Tolerance Abilities.

MLA

Suzuki, Masashi, et al. “Normalization of Hematocrit with Recombinant Human Erythropoietin in Chronic Hemodialysis Patients Does Not Fully Improve Their Exercise Tolerance Abilities.” Artificial Organs, vol. 19, no. 12, Dec. 1995, pp. 1258–61. EBSCOhost, https://doi.org/10.1111/j.1525-1594.1995.tb02296.x.

APA

Suzuki, M., Tsutsui, M., Yokoyama, A., & Hirasawa, Y. (1995). Normalization of Hematocrit with Recombinant Human Erythropoietin in Chronic Hemodialysis Patients Does Not Fully Improve Their Exercise Tolerance Abilities. Artificial Organs, 19(12), 1258–1261. https://doi.org/10.1111/j.1525-1594.1995.tb02296.x

Chicago

Suzuki, Masashi, Makiko Tsutsui, Akihiro Yokoyama, and Yosihei Hirasawa. 1995. “Normalization of Hematocrit with Recombinant Human Erythropoietin in Chronic Hemodialysis Patients Does Not Fully Improve Their Exercise Tolerance Abilities.” Artificial Organs 19 (12): 1258–61. doi:10.1111/j.1525-1594.1995.tb02296.x.